Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
385.2 GBX | -0.58% | +5.10% | +9.30% |
Mar. 25 | Chemring Director Ord sells GBP500,000 in shares | AN |
Mar. 18 | Stocks downbeat before central bank rate storm | AN |
Valuation
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 562.9 | 734.3 | 826.5 | 855.2 | 781.2 | 1,055 | - | - |
Enterprise Value (EV) 1 | 638.6 | 782.5 | 853.1 | 862.4 | 795.6 | 1,122 | 1,128 | 1,117 |
P/E ratio | 26.1 x | 21.7 x | 20.3 x | 17.9 x | 21.3 x | 19.9 x | 18 x | 16.3 x |
Yield | 1.79% | 1.5% | 1.64% | 1.89% | 2.47% | 2.03% | 2.25% | 2.52% |
Capitalization / Revenue | 1.49 x | 1.82 x | 2.1 x | 1.93 x | 1.65 x | 2.07 x | 1.91 x | 1.74 x |
EV / Revenue | 1.69 x | 1.94 x | 2.17 x | 1.95 x | 1.68 x | 2.21 x | 2.04 x | 1.84 x |
EV / EBITDA | 10.4 x | 10.5 x | 11.2 x | 10.5 x | 8.99 x | 11.6 x | 10.7 x | 9.65 x |
EV / FCF | 37.3 x | 22.3 x | 18.8 x | 20.3 x | 25.1 x | 135 x | 34.3 x | 22.8 x |
FCF Yield | 2.68% | 4.49% | 5.33% | 4.93% | 3.98% | 0.74% | 2.92% | 4.38% |
Price to Book | 1.76 x | 2.4 x | 2.39 x | 2.08 x | 2.13 x | 2.8 x | 2.48 x | 2.23 x |
Nbr of stocks (in thousands) | 280,052 | 281,893 | 282,580 | 283,180 | 279,515 | 272,329 | - | - |
Reference price 2 | 2.010 | 2.605 | 2.925 | 3.020 | 2.795 | 3.875 | 3.875 | 3.875 |
Announcement Date | 12/16/19 | 12/15/20 | 12/14/21 | 12/13/22 | 12/12/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 378.6 | 402.5 | 393.3 | 442.8 | 472.6 | 508.7 | 551.5 | 606.4 |
EBITDA 1 | 61.2 | 74.6 | 76.4 | 82.3 | 88.5 | 96.47 | 105.6 | 115.8 |
EBIT 1 | 44 | 54.7 | 57.5 | 64 | 69.2 | 73.5 | 80.78 | 90.22 |
Operating Margin | 11.62% | 13.59% | 14.62% | 14.45% | 14.64% | 14.45% | 14.65% | 14.88% |
Earnings before Tax (EBT) 1 | 26.7 | 43.3 | 48.8 | 51.8 | 44.1 | 67.4 | 74.73 | 83.43 |
Net income 1 | 21.9 | 34.7 | 41.5 | 47.4 | 37.7 | 54.27 | 59.37 | 66.23 |
Net margin | 5.78% | 8.62% | 10.55% | 10.7% | 7.98% | 10.67% | 10.76% | 10.92% |
EPS 2 | 0.0770 | 0.1200 | 0.1440 | 0.1690 | 0.1310 | 0.1948 | 0.2156 | 0.2380 |
Free Cash Flow 1 | 17.1 | 35.1 | 45.5 | 42.5 | 31.7 | 8.333 | 32.92 | 48.88 |
FCF margin | 4.52% | 8.72% | 11.57% | 9.6% | 6.71% | 1.64% | 5.97% | 8.06% |
FCF Conversion (EBITDA) | 27.94% | 47.05% | 59.55% | 51.64% | 35.82% | 8.64% | 31.18% | 42.22% |
FCF Conversion (Net income) | 78.08% | 101.15% | 109.64% | 89.66% | 84.08% | 15.36% | 55.46% | 73.79% |
Dividend per Share 2 | 0.0360 | 0.0390 | 0.0480 | 0.0570 | 0.0690 | 0.0788 | 0.0873 | 0.0978 |
Announcement Date | 12/16/19 | 12/15/20 | 12/14/21 | 12/13/22 | 12/12/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: October | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S2 |
---|---|---|---|---|---|---|---|
Net sales | 191 | 211.5 | 198.5 | 194.8 | 220.4 | 222.4 | - |
EBITDA | - | 39.4 | 37.6 | 38.8 | 42.8 | 39.5 | - |
EBIT 1 | - | 29.1 | - | 29.4 | 33.5 | 30.5 | 42.6 |
Operating Margin | - | 13.76% | - | 15.09% | 15.2% | 13.71% | - |
Earnings before Tax (EBT) 1 | - | - | 24.3 | 24.5 | 28.9 | 22.9 | 22.1 |
Net income 1 | - | - | 21.4 | 20.1 | 26.5 | 20.9 | 19 |
Net margin | - | - | 10.78% | 10.32% | 12.02% | 9.4% | - |
EPS 2 | 0.0690 | - | 0.0740 | 0.0700 | 0.0920 | 0.0740 | 0.0650 |
Dividend per Share 2 | - | - | 0.0160 | 0.0320 | 0.0190 | 0.0380 | 0.0460 |
Announcement Date | 6/3/20 | 12/15/20 | 6/3/21 | 12/14/21 | 6/8/22 | 12/13/22 | 12/12/23 |
Balance Sheet Analysis
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 75.7 | 48.2 | 26.6 | 7.2 | 14.4 | 67.1 | 72.6 | 61.4 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.237 x | 0.6461 x | 0.3482 x | 0.0875 x | 0.1627 x | 0.6958 x | 0.6873 x | 0.5302 x |
Free Cash Flow 1 | 17.1 | 35.1 | 45.5 | 42.5 | 31.7 | 8.33 | 32.9 | 48.9 |
ROE (net income / shareholders' equity) | 11.4% | 8.18% | 14% | 14.7% | 14.3% | 14.8% | 14.7% | 14.4% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 1.150 | 1.090 | 1.220 | 1.450 | 1.310 | 1.380 | 1.560 | 1.740 |
Cash Flow per Share 2 | 0.2200 | 0.2600 | 0.2600 | 0.2800 | - | -0.1900 | -0.0400 | 0.0200 |
Capex 1 | 44.8 | 40.8 | 30.2 | 34.5 | 34.2 | 71.8 | 53.1 | 45.2 |
Capex / Sales | 11.83% | 10.14% | 7.68% | 7.79% | 7.24% | 14.11% | 9.63% | 7.45% |
Announcement Date | 12/16/19 | 12/15/20 | 12/14/21 | 12/13/22 | 12/12/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.30% | 1.32B | |
+20.30% | 134B | |
+10.34% | 78.49B | |
+3.89% | 71.98B | |
+20.06% | 50.34B | |
+34.70% | 42.56B | |
+0.54% | 40.16B | |
+40.66% | 31.56B | |
+78.68% | 23.98B | |
+20.61% | 23.51B |
- Stock Market
- Equities
- CHG Stock
- Financials Chemring Group PLC